Tech Company Financing Transactions
Corden Pharma - A Full-Service CDMO Funding Round
Harris & Harris Group joined a Series A funding round for Corden Pharma - A Full-Service CDMO. The funding round closed on 6/5/2007.
Transaction Overview
Company Name
Announced On
6/5/2007
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Otto-Hahn-Straße
Plankstadt, 68723
Germany
Plankstadt, 68723
Germany
Phone
Website
Email Address
Overview
Multi-kg manufacturing of carbohydrate-derived bulding blocks (monosccharides) and conjugates (glycolipids and glycopeptides)for oligosaccharides.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Quirmbach
Chief Financial Officer
Heiko Serwe
VP - Marketing
Stephen Houldsworth
VP - Sales
Mimoun Ayoub
Browse more venture capital transactions:
Prev: 6/5/2007: InsideView venture capital transaction
Next: 6/5/2007: ShotSpotter venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs